title: ADAM17 and CD56low CD16low NK cells.
authors: Department of Medicine Blood and Marrow Transplant Program, Washington University School of Medicine, Saint Louis, MO, USA rromee@dom.wustl.edu mille011@umn.edu.
authors: Rizwan
authors: R
authors: Romee
authors: Department of medicine, Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA rromee@dom.wustl.edu mille011@umn.edu.
authors: Jeffrey S
authors: JS
authors: Miller
mesh_terms: D001854:Bone Marrow Cells / Q000378:metabolism*; D019002:CD56 Antigen / Q000378:metabolism*; D006801:Humans; D016130:Immunophenotyping; D007694:Killer Cells, Natural / Q000378:metabolism*; D007938:Leukemia / Q000378:metabolism*; D016131:Lymphocyte Subsets / Q000378:metabolism*; D017452:Receptors, IgG / Q000378:metabolism*
chemical_list: D019002:CD56 Antigen; D017452:Receptors, IgG
keywords: ADAM17 expression; CD16low; CD56low; cell development; natural killer cell function